,drug_name,section_name,gpt_output
0,XEOMIN,boxed warnings,"Asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, swallowing difficulties."
1,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, dysphagia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, dysarthria, urinary incontinence, breathing difficulties, asthenia, asthma, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, neck muscle weakness, neck muscle atrophy, neck muscle tenderness, nausea, pyrexia, bradycardia, hypotension, corneal exposure, corneal ulceration, ectropion, reduced blinking, narrow angle glaucoma, injection site ecchymosis, death."
2,QUTENZA,adverse reactions,"Application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, death."
3,QUTENZA,warnings and precautions,"Eye exposure, mucous membrane exposure, coughing, sneezing, irritation of eyes or airway, increased blood pressure, hypertension, pain, death."
4,ZYTIGA,adverse reactions,"Hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, death, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, cardiac disorder, injury, poisoning and procedural complications, musculoskeletal and connective tissue disorders, gastrointestinal disorders, infections and infestations, respiratory, thoracic and mediastinal disorders, renal and urinary disorders, injury, poisoning and procedural complications, cardiovascular adverse reactions, respiratory, thoracic and mediastinal disorders, musculoskeletal and connective tissue disorders, rhabdomyolysis, non-infectious pneumonitis."
5,ZYTIGA,warnings and precautions,"Hypertension, hypokalemia, fluid retention, cardiovascular disease, left ventricular ejection fraction <50%, New York Heart Association (NYHA) Class II to IV heart failure, adrenocortical insufficiency, infection, stress, liver enzyme increases, liver test elevation, hepatotoxicity, liver function impairment, death."
6,TOVIAZ,adverse reactions,"Dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, peripheral edema, back pain, insomnia, increased alanine aminotransferase, increased gamma glutamyltransferase, rash, blurred vision, palpitations, hypersensitivity reactions including angioedema with airway obstruction and face edema, dizziness, headache, somnolence, urticaria, pruritus"
7,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, decreased gastrointestinal motility, narrow-angle glaucoma, somnolence, headache, dizziness, hepatic impairment, severe renal impairment, interaction with CYP3A4 inhibitors, myasthenia gravis, death."
8,STRIBILD,adverse reactions,"Lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, abdominal pain, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, depression, suicidal ideation, suicide attempt, abnormal dreams, insomnia, skin discoloration, hepatitis, jaundice, somnolence, headache, dizziness, fatigue, rash, proteinuria, serum creatinine increases, decreased estimated creatinine clearance, alanine aminotransferase (ALT) increases, alkaline phosphatase increases, bilirubin increases, serum glucose abnormalities, glycosuria, neutrophil count decreases, fasting cholesterol increases, fasting triglycerides increases, dyspnea, pancreatitis, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes, rash, asthenia, lactic acidosis, hypokalemia, hypophosphatemia, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, polyuria, death."
9,STRIBILD,boxed warnings,"Lactic acidosis, severe hepatomegaly with steatosis, fatal cases, post treatment acute exacerbation of hepatitis B, hepatitis B virus, discontinuation of EMTRIVA or VIREAD, hepatic function monitoring, anti-hepatitis B therapy, not approved for chronic hepatitis B virus (HBV) infection, fatal cases, nucleoside analogs, tenofovir disoproxil fumarate."
10,STRIBILD,warnings and precautions,"Renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, hepatitis B exacerbations, decreases in bone mineral density, bone fractures, muscular pain or weakness, immune reconstitution syndrome, fat redistribution, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, Graves' disease, polymyositis, Guillain-Barre syndrome, death."
11,FARXIGA,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Death, Female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures."
12,FARXIGA,warnings and precautions,"Hypotension, intravascular volume contraction, elderly patients, impaired renal function, low systolic blood pressure, loop diuretics, hypovolemia, renal impairment, impairment in renal function, decreased eGFR, genital mycotic infections, urinary tract infections, female genital mycotic infections, male genital mycotic infections, increased LDL-C, bladder cancer, death."
13,VICTRELIS,adverse reactions,"Fatigue, anemia, nausea, headache, dysgeusia, neutropenia, vomiting, diarrhea, dry mouth, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, death, agranulocytosis, pancytopenia, thrombocytopenia, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma."
14,VICTRELIS,warnings and precautions,"Anemia, neutropenia, pancytopenia, embryofetal toxicity, death, hypersensitivity, thromboembolic events."
15,VIMIZIM,adverse reactions,"Pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, anaphylaxis, hypersensitivity reactions, death."
16,VIMIZIM,boxed warnings,"Anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms (e.g., nausea, abdominal pain, retching, and vomiting), hypersensitivity reactions, respiratory compromise, death."
17,VIMIZIM,warnings and precautions,"Anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms (e.g., nausea, abdominal pain, retching, and vomiting), peripheral edema, sleep apnea, febrile or respiratory illness, back pain, paralysis of limbs below the level of compression, urinary and fecal incontinence, death."
18,BEPREVE,adverse reactions,"Mild taste following instillation, eye irritation, headache, nasopharyngitis, death, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat."
19,BEPREVE,warnings and precautions,"adverse reactions, fatal events"
20,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease and Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, LDL cholesterol increased, triglycerides increased, proteinuria, hypertension, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, tachycardia, death."
21,PRISTIQ,boxed warnings,"Suicidal thoughts and behaviors, worsening of symptoms, emergence of suicidal thoughts, increased risk of suicidal thinking, suicidal thoughts, suicidal behavior, worsening symptoms, emergence of suicidal thoughts, increased risk of suicidal thinking, death."
22,PRISTIQ,warnings and precautions,"Worsening of depression, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, death, dizziness, nausea, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, irritability, agitation, dystonia, akathisia, seizures."
23,TAFINLAR,adverse reactions,"New primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, hypertension, pneumonitis or interstitial lung disease, death."
24,TAFINLAR,warnings and precautions,"Retinal vein occlusion, interstitial lung disease, new primary malignancies (cutaneous and non-cutaneous), tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities (retinal pigment epithelial detachment, uveitis, iritis), serious febrile reactions, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, death."
25,MULTAQ,adverse reactions,"Diarrhea, nausea, abdominal pain, vomiting, asthenia, bradycardia, rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increased creatinine, QTc prolongation, death (new or worsening heart failure, liver injury, interstitial lung disease including pneumonitis and pulmonary fibrosis, anaphylactic reactions including angioedema, vasculitis, including leukocytoclastic vasculitis)"
26,MULTAQ,boxed warnings,"Increased risk of death, stroke, heart failure, doubles the risk of death, hospitalization for heart failure, death, stroke, heart failure."
27,MULTAQ,warnings and precautions,"Cardiac rhythm disorders (including atrial fibrillation, AF), discontinuation, cardioversion, Hepatic injury, liver injury, liver failure, acute liver failure, hepatic enzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, serum bilirubin, Pulmonary toxicity, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, Hypokalemia, hypomagnesemia, potassium-depleting diuretics, QT interval prolongation, QTc (Bazett) prolongation, Renal impairment, pre-renal azotemia, acute renal failure, serum creatinine, creatinine's tubular secretion, Fetal harm, premenopausal women, women of childbearing potential, effective contraception, death"
28,TANZEUM,adverse reactions,"Thyroid C-cell tumors, acute pancreatitis, hypoglycemia with concomitant use of insulin secretagogues or insulin, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, hypoglycemia, pneumonia, atrial fibrillation, atrial flutter, appendicitis, anti-albiglutide antibodies, anti-GLP-1 antibodies, anti-human albumin antibodies, liver enzyme abnormalities, death."
29,TANZEUM,boxed warnings,"Thyroid C-cell tumors, medullary thyroid carcinoma (MTC), death"
30,TANZEUM,warnings and precautions,"Thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure, death."
31,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased Blood Lactate Dehydrogenase, decreased Appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, anemia, febrile neutropenia, fatigue, multi-organ failure, ventricular fibrillation."
32,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia (neutropenia, lymphopenia), anemia, infection (pneumonia, sepsis), hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, gastrointestinal toxicity (nausea, vomiting, diarrhea), genotoxicity, embryo-fetal toxicity, teratogenicity, embryo-fetal lethality, death."
33,HALAVEN,adverse reactions,"Neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, thrombocytopenia, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death."
34,HALAVEN,warnings and precautions,"Neutropenia, febrile neutropenia, Grade 4 neutropenia, cytopenias, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, peripheral motor neuropathy, peripheral sensory neuropathy, fetal harm, embryo-fetal toxicity, teratogenicity, QT prolongation, congestive heart failure, bradyarrhythmias, electrolyte abnormalities, hypokalemia, hypomagnesemia, congenital long QT syndrome, death."
35,XIAFLEX,adverse reactions,"edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in extremity, tenderness, injection site swelling, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, blood blister, injection site hematoma, injection site swelling, ecchymosis, tendon rupture, death, penile hematoma, penile swelling, penile pain, penile ecchymoses, blood blister, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, corporal rupture, severe penile hematoma, death."
36,XIAFLEX,boxed warnings,"Corporal rupture, penile fracture, penile injury, severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, death."
37,XIAFLEX,warnings and precautions,"Tendon rupture, ligament damage, skin laceration, pulley rupture, complex regional pain syndrome, sensory abnormality of the hand, skin laceration (tear), corporal rupture (penile fracture), penile ecchymoses or hematoma, severe penile hematoma, anaphylaxis, bleeding, ecchymosis/contusion, injection site hemorrhage."
38,CIMZIA,adverse reactions,"Upper respiratory tract infection, rash, urinary tract infection, abdominal pain, diarrhea, intestinal obstruction, pyrexia, urticaria, pneumonia, menstrual disorder, thrombophlebitis, vasculitis, hypertensive adverse reactions, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, acute bronchitis, fatigue, back pain, headache."
39,CIMZIA,boxed warnings,"Serious infections, tuberculosis, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Legionella, Listeria, sepsis, opportunistic pathogens, malignancy, lymphoma, death."
40,CIMZIA,warnings and precautions,"Serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis or serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, death."
41,GRANIX,adverse reactions,"Bone pain, splenic rupture, acute respiratory distress syndrome, serious allergic reactions, capillary leak syndrome, tumor growth, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, death."
42,GRANIX,warnings and precautions,"Splenic rupture, Acute Respiratory Distress Syndrome (ARDS), allergic reactions (angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria), sickle cell crisis, capillary leak syndrome, death."
43,TUDORZA,adverse reactions,"Paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, death."
44,TUDORZA,warnings and precautions,"Paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions (including anaphylaxis, angioedema, urticaria, rash, bronchospasm, or itching), death."
45,JEVTANA,adverse reactions,"Neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, sepsis or septic shock, infections, febrile neutropenia, renal failure, ventricular fibrillation, cerebral hemorrhage, dyspepsia, pain, urinary tract infection, dehydration, gastritis, intestinal obstruction, increased AST, increased ALT, increased bilirubin, death."
46,JEVTANA,boxed warnings,"Neutropenia, neutrophil counts of <=1,500 cells/mm3, neutrophil counts, leukopenia, severe hypersensitivity, generalized rash/erythema, hypotension, bronchospasm, contraindicated, history of severe hypersensitivity reactions to JEVTANA, history of severe hypersensitivity reactions to drugs formulated with polysorbate 80, deaths."
47,JEVTANA,warnings and precautions,"Neutropenia, anemia, thrombocytopenia, pancytopenia, febrile neutropenia, gastrointestinal disorders (nausea, vomiting, diarrhea, gastrointestinal hemorrhage, perforation, ileus, enterocolitis, neutropenic enterocolitis), renal failure, death, hypersensitivity reactions (generalized rash/erythema, hypotension, bronchospasm), hemoglobin < 10 g/dL, increased complications from prolonged neutropenia, sepsis or septic shock, electrolyte imbalance, age, poor performance status, previous episodes of febrile neutropenia, extensive prior radiation ports, poor nutritional status, other serious comorbidities, therapeutic use of G-CSF, secondary prophylaxis, intensive measures, anti-diarrheal or anti-emetic medications, treatment delay or dosage reduction, dehydration, obstructive uropathy, neutropenia and febrile neutropenia, severe hepatic impairment, total bilirubin > 3 * ULN, mild or moderate hepatic impairment, total bilirubin > 1 to <= 1.5 * ULN or AST > 1.5 * ULN, any AST, embryotoxic, fetotoxic, abortifacient, female patients, pregnant women, hazard to the fetus."
48,ILARIS,adverse reactions,"Infections (predominantly of the upper respiratory tract), nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, serious infections, vertigo, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, urinary tract infection, gastroenteritis, viral infection, viral upper respiratory tract infection, rhinitis, pharyngitis, tonsillitis, sinusitis, adenovirus, lymph node abscess, sepsis, otitis media, sinusitis, measles, death."
49,ILARIS,warnings and precautions,"Serious infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, opportunistic infections, malignancies, hypersensitivity reactions, anaphylactic reactions, live vaccine inefficacy, macrophage activation syndrome, death."
50,AMPYRA,adverse reactions,"Urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, death (indirect, as seizures can lead to fatal outcomes)."
51,AMPYRA,warnings and precautions,"Seizures, anaphylaxis, death, urinary tract infections."
52,SIRTURO,adverse reactions,"Increased mortality, QT prolongation, hepatotoxicity, drug interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, death."
53,SIRTURO,boxed warnings,"Increased mortality, death, QT prolongation, ventricular arrhythmia, death"
54,SIRTURO,warnings and precautions,"QT prolongation, death, hepatotoxicity, ventricular arrhythmia, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium or magnesium or potassium levels below normal, alcohol consumption, hepatic function impairment, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, syncope."
55,ADREVIEW,adverse reactions,"Dizziness, rash, pruritus, flushing, injection site hemorrhage, headache, injection site problems such as hematoma and bruising, hypersensitivity reactions, death."
56,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, death, withdrawal of medically necessary drugs, false negative imaging results, benzyl alcohol toxicity, gasping syndrome, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, delayed elimination of the drug, decreased quality of scintigraphic images, conditions that affect the sympathetic nervous system, Parkinsonian syndromes, Parkinson's disease, multiple system atrophy, thyroid neoplasia, hypertension, transient episode of hypertension."
57,ARCAPTA,adverse reactions,"Asthma-related death, Cough, Oropharyngeal pain, Nasopharyngitis, Headache, Nausea, COPD exacerbation, Pneumonia, Angina pectoris, Atrial fibrillation, Muscle spasm, Musculoskeletal pain, Peripheral edema, Diabetes mellitus, Hyperglycemia, Sinusitis, Upper respiratory tract infection, Bronchospasm (postmarketing), Hypersensitivity reactions (postmarketing), Tachycardia/heart rate increase/palpitations (postmarketing), Pruritus/rash (postmarketing), Dizziness (postmarketing)"
58,ARCAPTA,boxed warnings,"Asthma-related death, increased risk of asthma-related death, salmeterol, class effect of LABA, indacaterol, ARCAPTA NEOHALER"
59,ARCAPTA,warnings and precautions,"asthma-related death, asthma exacerbation, cardiovascular effects, convulsive disorders, coronary insufficiency, cardiac arrhythmias, hypertension, hypersensitivity reactions, hypokalemia, hyperglycemia, paradoxical bronchospasm, thyrotoxicosis, use in conjunction with other medications containing long-acting beta2-agonists, death"
60,INTELENCE,adverse reactions,"rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, increased pancreatic amylase, increased lipase, increased creatinine, decreased hemoglobin, decreased white blood cell count, decreased neutrophils, decreased platelet count, increased total cholesterol, increased low density lipoprotein, increased triglycerides, increased glucose levels, increased alanine aminotransferase, increased aspartate aminotransferase, hepatitis B and/or hepatitis C virus co-infection, death."
61,INTELENCE,warnings and precautions,"Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, hypersensitivity reaction, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), severe rash, rash with systemic symptoms, liver transaminase elevations, death, fat redistribution, immune reconstitution syndrome"
62,PICATO,adverse reactions,"Local skin reactions (including erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, and erosion/ulceration), application site pain, application site pruritus, application site infection, periorbital edema, headache, nasopharyngitis, application site irritation, eyelid edema, eye pain, and conjunctivitis"
63,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling, vesiculation/pustulation, erosion/ulceration, death"
64,VIZAMYL,adverse reactions,"Flushing, increased blood pressure, headache, nausea, dizziness, hypersensitivity reaction, death."
65,VIZAMYL,warnings and precautions,"Hypersensitivity reactions (flushing, dyspnea), false positives, radiation risk, brain atrophy, motion artifacts, cancer, death."
66,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, death, nausea, constipation, dyspepsia, influenza, weight increased, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, urinary retention, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
67,POTIGA,boxed warnings,"Retinal abnormalities, retinal pigment dystrophies, damage to the photoreceptors, vision loss, abnormal visual acuity, decreased visual acuity, progression of retinal abnormalities, reversibility of retinal abnormalities, vision changes, death."
68,POTIGA,warnings and precautions,"Urinary retention, hydronephrosis, renal function impairment, death, retinal abnormalities, vision loss, skin discoloration, neuropsychiatric symptoms (confusional state, psychotic symptoms, hallucinations), dizziness, somnolence, QT interval prolongation, suicidal thoughts or behavior."
69,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, asthma-related deaths, increased risk of pneumonia in COPD, immunosuppression, hypercorticism and adrenal suppression, reduction in bone mineral density, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism and adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, oral candidiasis, headache, influenza, upper respiratory tract infection, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough."
70,BREO,boxed warnings,"Asthma-related death, increased risk of asthma-related death, placebo-controlled trial, salmeterol, class effect of LABA, increased risk of asthma-related hospitalization, pediatric and adolescent patients, long-acting beta2-adrenergic agonists (LABA), vilanterol, inhaled corticosteroids (ICS), long-term asthma control medications."
71,BREO,warnings and precautions,"Asthma-related death, hospitalization, increased risk of pneumonia, impaired adrenal function, hypercorticism and adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decreased bone mineral density, glaucoma and cataracts, hypokalemia and hyperglycemia, local effects of inhaled corticosteroids (Candida albicans infection), immunosuppression, infections (tuberculosis, fungal, bacterial, viral, or parasitic infections, ocular herpes simplex), chickenpox, measles, death."
72,DOTAREM,adverse reactions,"NSF, death, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions (including site inflammation, extravasation, pruritus, and warmth), bradycardia, tachycardia, arrhythmia, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis."
73,DOTAREM,boxed warnings,"Nephrogenic systemic fibrosis (NSF), fatal or debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organs fibrosis, death."
74,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis (NSF), death, anaphylactoid/anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, circulatory collapse, hypersensitivity reactions, acute kidney injury, acute kidney injury requiring dialysis, tissue irritation."
75,NESINA,adverse reactions,"Nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, death."
76,NESINA,warnings and precautions,"Acute pancreatitis, death, hypersensitivity reactions (anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome), hepatic failure, liver injury, fatty liver disease, hypoglycemia, arthralgia, severe joint pain."
77,EYLEA,adverse reactions,"Conjunctival hemorrhage, eye pain, cataract, vitreous detachment, vitreous floaters, increased intraocular pressure, intraocular inflammation, corneal epithelium defect, retinal pigment epithelium detachment, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, eye inflammation, retinal tear, endophthalmitis, corneal edema, death."
78,EYLEA,warnings and precautions,"Endophthalmitis, retinal detachments, increase in intraocular pressure, thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death."
79,TECFIDERA,adverse reactions,"Anaphylaxis, angioedema, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, increased aspartate aminotransferase, lymphopenia, death."
80,TECFIDERA,warnings and precautions,"Anaphylaxis, angioedema, death, prolonged lymphopenia, disturbance of vision, changes in thinking, memory, and orientation leading to confusion and personality changes, serious infections."
81,TREANDA,adverse reactions,"Myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, hypersensitivity, hypertension, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, worsening hypertension, hypersensitivity, pyrexia, diarrhea, nasopharyngitis, infection, herpes simplex, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, nasopharyngitis, weight decreased, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, death."
82,TREANDA,warnings and precautions,"Myelosuppression, neutropenic sepsis, diffuse alveolar hemorrhage, pneumonia from an opportunistic infection, infections, pneumonia, sepsis, septic shock, death, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, rash, toxic skin reactions, bullous exanthema, toxic epidermal necrolysis, Stevens-Johnson syndrome, other malignancies, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasation injury, death."
83,ELIQUIS,adverse reactions,"Bleeding, including intracranial bleed, gastrointestinal (GI) bleed, fatal bleeding, Hypersensitivity reactions, such as skin rash and anaphylactic reactions, Syncope, Thrombotic events after premature discontinuation, Death (fatal bleeding, intracranial bleeding, non-intracranial bleeding), Increased transaminases (alanine aminotransferase increased and alanine aminotransferase abnormal), Increased aspartate aminotransferase, Increased gamma-glutamyltransferase, Hematuria, Blood and lymphatic system disorders, such as thrombocytopenia, Vascular disorders, such as hypotension, Respiratory, thoracic, and mediastinal disorders, such as epistaxis, Gastrointestinal disorders, such as gastrointestinal hemorrhage, hematemesis, melena, and hematochezia, Hepatobiliary disorders, such as liver function test abnormal, blood alkaline phosphatase increased, and blood bilirubin increased."
84,ELIQUIS,boxed warnings,"Thrombotic events, premature discontinuation of Eliquis, spinal/epidural hematoma, long-term or permanent paralysis, pathological bleeding, increased risk, neuraxial anesthesia, spinal puncture, indwelling epidural catheters, concomitant use of other drugs that affect hemostasis, nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, anticoagulants, traumatic or repeated epidural or spinal punctures, spinal deformity, spinal surgery, neurological impairment, neurological compromise, urgent treatment, hemorrhage, death."
85,ELIQUIS,warnings and precautions,"Bleeding, serious bleeding, potentially fatal bleeding, increased risk of bleeding, thrombotic events, stroke, pathological bleeding, active pathological hemorrhage, blood loss, long-term or permanent paralysis, epidural or spinal hematoma, neurological impairment, numbness, weakness of the legs, bowel or bladder dysfunction, death."
86,BOSULIF,adverse reactions,"The adverse reactions mentioned in the text are: diarrhea, gastrointestinal toxicity, abdominal pain, gastritis, acute pancreatitis, gastrointestinal hemorrhage, nausea, vomiting, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, edema, Arthralgia, back pain, asthenia, pruritus, dyspnea, thrombocytopenia, rash, anemia, pyrexia, fatigue, QTcF interval of greater than 500 milliseconds, platelet count (low), absolute neutrophil count (low), hemoglobin (low), SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, lipase greater than 2*ULN, phosphorus (low), total bilirubin greater than 3.0*ULN, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, chest pain, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, abnormal hepatic function, liver disorder, liver injury, drug hypersensitivity, anaphylactic shock, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, pruritus, acne, erythema multiforme, exfoliative rash, drug eruption, death."
87,BOSULIF,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, gastrointestinal toxicity, thrombocytopenia, anemia, neutropenia, increased ALT or AST, drug induced liver injury, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, decline in estimated glomerular filtration rate, death"
88,GILENYA,adverse reactions,"bradycardia, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, migraine, nausea, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, death"
89,GILENYA,warnings and precautions,"Bradycardia, atrioventricular block, decreased heart rate, first-degree AV block, second-degree AV block, transient AV conduction delays, third-degree AV block, junctional escape, infections, serious infections, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections (including death), varicella zoster, herpes simplex, disseminated herpetic infections, encephalitis, multiorgan failure, cryptococcal infections, cryptococcal meningitis, progressive multifocal leukoencephalopathy (PML) (including death), macular edema, blurred vision, decreased visual acuity, diabetes mellitus, uveitis, posterior reversible encephalopathy syndrome (PRES), sudden onset of severe headache, altered mental status, visual disturbances, seizure, dyspnea, reduced forced expiratory volume over 1 second (FEV1), reduced diffusion lung capacity for carbon monoxide (DLCO), compromised respiratory function, elevations of liver enzymes, transaminase, bilirubin."
90,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions including Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, death."
91,BENLYSTA,warnings and precautions,"Mortality, deaths, infections, pneumonia, urinary tract infection, cellulitis, bronchitis, infection leading to discontinuation of treatment, infection resulting in death, Progressive Multifocal Leukoencephalopathy (PML), JC virus-associated PML, malignancies, non-melanoma skin cancers, hypersensitivity reactions, anaphylaxis, infusion reactions, bradycardia, myalgia, headache, rash, urticaria, hypotension, depression, suicidal thoughts, insomnia, anxiety, death."
92,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, pneumonia, pulmonary embolism, ILD, sepsis, arrhythmia, dyspnea, fatigue, neuropathy, rash, renal cyst, syncope, pyrexia, weight decreased, muscle spasm, abdominal pain, dysphagia, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, diabetic ketoacidosis, septic shock, acute respiratory failure, death."
93,XALKORI,warnings and precautions,"Hepatotoxicity, liver testing, death, Interstitial Lung Disease, pneumonitis, QT Interval Prolongation, bradycardia, death, severe visual loss, death, embryofetal toxicity, pregnancy."
94,CLEVIPREX,adverse reactions,"Hypotension, Reflex tachycardia, Headache, Nausea, Vomiting, Acute renal failure, Atrial fibrillation, Myocardial infarction, Cardiac arrest, Syncope, Dyspnea, Increased blood triglycerides, Ileus, Hypersensitivity, Decreased oxygen saturation (possible pulmonary shunting), Death"
95,CLEVIPREX,warnings and precautions,"Hypotension, reflex tachycardia, death, negative inotropic effects, rebound hypertension"
96,LUMIZYME,adverse reactions,"Hypersensitivity reactions, including: Anaphylaxis, Rash, Pyrexia, Flushing/feeling hot, Urticaria, Headache, Hyperhidrosis, Nausea, Cough, Decreased oxygen saturation, Tachycardia, Tachypnea, Chest discomfort, Dizziness, Muscle twitching, Agitation, Cyanosis, Erythema, Hypertension/increased blood pressure, Pallor, Rigors, Tremor, Vomiting, Fatigue, Myalgia, Angioedema, Throat tightness, Chest pain/discomfort, Supraventricular tachycardia, Hyperhidrosis, Headache, Nausea, Urticaria, Dizziness, Chest discomfort, Muscle twitching, Myalgia, Flushing/feeling hot, Increased blood pressure, Vomiting, Peripheral edema, Pruritus, Rash papular, Throat tightness, Death (implied due to anaphylaxis)"
97,LUMIZYME,boxed warnings,"Anaphylaxis, hypersensitivity reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, immune-mediated reactions, proteinuria, nephrotic syndrome, necrotizing skin lesions, cardiac compromise, respiratory compromise, cardiorespiratory failure, fluid overload, death."
98,LUMIZYME,warnings and precautions,"Anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema (including tongue or lip swelling, periorbital edema, and face edema), urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, death, immune-mediated reactions, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, acute underlying respiratory illness, compromised cardiac and/or respiratory function, acute cardiorespiratory failure, cardiac arrhythmia, sudden cardiac death, antibody development, IgG antibodies, reduced clinical efficacy, ventilator dependence."
99,CERDELGA,adverse reactions,"Fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, death."
100,CERDELGA,warnings and precautions,"Cardiac arrhythmias, long QT syndrome, congestive heart failure, recent acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, death."
101,NEURACEQ,adverse reactions,"Injection site reaction, erythema, irritation, pain, death"
102,NEURACEQ,warnings and precautions,"Image misinterpretation, false positives, radiation risk, long-term cumulative radiation exposure, cancer"
103,PROLIA,adverse reactions,"Hypocalcemia, serious infections, dermatologic reactions (such as dermatitis, eczema, and rashes), osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, death, drug-related hypersensitivity reactions (anaphylaxis, rash, urticaria, facial swelling, and erythema), musculoskeletal pain (including severe cases), and parathyroid hormone increased."
104,PROLIA,warnings and precautions,"Hypersensitivity, anaphylactic reactions, hypocalcemia, worsening hypocalcemia in renal impairment, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, abdominal infections, urinary tract infections, ear infections, endocarditis, opportunistic infections, dermatologic adverse reactions, dermatitis, eczema, rashes, musculoskeletal pain, bone pain, joint pain, death."
105,FANAPT,adverse reactions,"Dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, tremor, lethargy, ejaculation failure, dyspnea, hypotension, abdominal discomfort, palpitations, vertigo, tinnitus, hypothyroidism, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, cholelithiasis, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, retrograde ejaculation, death."
106,FANAPT,boxed warnings,"Increased mortality, death, cardiovascular, heart failure, sudden death, infectious, pneumonia, dementia-related psychosis, traditional antipsychotic drugs."
107,FANAPT,warnings and precautions,"Increased mortality, cerebrovascular-related adverse events including stroke, QT prolongation, arrhythmia, sudden death, neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, weight gain, metabolic changes, cardiovascular/cerebrovascular risk, death."
108,FULYZAQ,adverse reactions,"Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count, death."
109,FULYZAQ,warnings and precautions,"Infectious etiologies of diarrhea, worsening of disease, not receiving appropriate therapy, death."
110,EOVIST,adverse reactions,"Nausea, headache, feeling hot, dizziness, back pain, vomiting, increased blood pressure, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, hypersensitivity reactions (anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough and pallor), tachycardia, restlessness, death."
111,EOVIST,boxed warnings,"Nephrogenic systemic fibrosis (NSF), chronic kidney disease, severe kidney disease, acute kidney injury, reduced renal function, death."
112,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis (NSF), hypersensitivity, anaphylactoid/hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, shock, death, acute kidney injury, acute renal failure, kidney toxicity, serum creatinine levels, estimated GFR, chronic kidney disease, moderate kidney disease, mild kidney disease, renal impairment, hemodialysis, muscle fibrosis, skin fibrosis, internal organs fibrosis, fibrosis, bronchial asthma, allergic disorders, resuscitation, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, local tissue reactions, myocyte necrosis, inflammation, laboratory tests interference, serum iron determination, visualization of liver lesions, severe renal or hepatic failure, serum ferritin levels, abnormally high serum bilirubin."
113,ONFI,adverse reactions,"Somnolence, sedation, lethargy, drooling, pyrexia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, respiratory depression, rash, urticaria, angioedema, and facial and lip edema, death."
114,ONFI,warnings and precautions,"Somnolence or Sedation, potentiation of sedation, withdrawal symptoms, physical and psychological dependence, death, suicidal behavior and ideation, serous dermatological reactions (including Stevens-Johnson syndrome and toxic epidermal necrolysis)"
115,COMETRIQ,adverse reactions,"Diarrhea, stomatitis, palmar-plantar erythrodysesthesia syndrome (PPES), decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, hypertension, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, hemorrhage, pneumonia, septicemia, fistulas, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, malignant hypertension, hypomagnesemia, hypokalemia, hyponatremia, overt hypertension, increased blood pressure, normal: grade 0: systolic < 120 mm Hg and diastolic < 80 mm Hg, pre-hypertension: systolic >= 120 mm Hg or diastolic >= 80 mm Hg, stage 1: systolic >= 140 mm Hg or diastolic >= 90 mm Hg, stage 2: systolic >= 160 mm Hg or diastolic >= 100 mm Hg, malignant: diastolic >= 120 mm Hg, death."
116,COMETRIQ,boxed warnings,"Perforations, fistulas, hemorrhage, gastrointestinal perforations, fistula formation, hemoptysis, gastrointestinal hemorrhage, death."
117,COMETRIQ,warnings and precautions,"Thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolic events, death, wound complications, dehiscence, hemorrhage, hypertension, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), death, perforations, fistulas, gastrointestinal perforations, non-gastrointestinal fistulas, gastrointestinal hemorrhage, tracheal/esophageal fistulas, fatal hemorrhage, venous thromboembolism, arterial thromboembolism, severe hepatic impairment, embryo-fetal toxicity, death."
118,NULOJIX,adverse reactions,"Anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, post-transplant lymphoproliferative disorder (PTLD), CNS PTLD, non-CNS PTLD, malignancies excluding non-melanoma skin cancer, non-melanoma skin cancer, progressive multifocal leukoencephalopathy (PML), tuberculosis, herpes infections, fungal infections, BK virus-associated nephropathy, cryptococcal meningitis, drug hypersensitivity, infusion-related reactions, proteinuria, antibodies directed against the belatacept molecule, death (in case of PML)."
119,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), CNS involvement, increased susceptibility to infection, malignancies, graft loss, death"
120,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), malignancies, skin malignancies, Progressive Multifocal Leukoencephalopathy (PML), bacterial infections, viral infections, fungal infections, protozoal infections, tuberculosis, polyoma virus nephropathy, death."
121,GILOTRIF,adverse reactions,"Diarrhea, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, death, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, pancreatitis."
122,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, death, bullous skin disorders, blistering lesions, exfoliating lesions, life-threatening cutaneous reactions, interstitial lung disease, ILD, renal impairment, hepatic impairment, death, hepatic toxicity, fatal hepatic impairment, keratitis, eye inflammation, ulcerative keratitis, embryofetal toxicity, death."
123,DATSCAN,adverse reactions,"Hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, death, rash, pruritis, injection site pain."
124,DATSCAN,warnings and precautions,"Hypersensitivity reactions, skin erythema, pruritis, death"
125,KALBITOR,adverse reactions,"Hypersensitivity reactions, including anaphylaxis, Headache, Nausea, Diarrhea, Pyrexia, Injection site reactions (local pruritus, erythema, pain, irritation, urticaria, and/or bruising), Nasopharyngitis, Vomiting, Pruritus, Upper abdominal pain, Fatigue, Upper respiratory tract infection, Death"
126,KALBITOR,boxed warnings,"Anaphylaxis, death"
127,KALBITOR,warnings and precautions,"Anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rash, urticaria, throat irritation, wheezing, hypotension, death."
128,APTIOM,adverse reactions,"Suicidal behavior and ideation, Serious dermatologic reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic reactions and angioedema, Hyponatremia, Neurological adverse reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, Dizziness, Somnolence, Nausea, Headache, Diplopia, Vomiting, Fatigue, Vertigo, Ataxia, Blurred vision, Tremor, Hypertension, Rash, Increases in total cholesterol, triglycerides, and LDL, Increases in creatine phosphokinase, Decreases in hemoglobin and hematocrit, Urinary tract infections, Fall, Cough, Balance disorder, Memory impairment, Nystagmus, Depression, Insomnia"
129,APTIOM,warnings and precautions,"Suicidal thoughts or behavior, depression, death, dermatologic reactions (Stevens-Johnson Syndrome, toxic epidermal necrolysis), anaphylaxis, angioedema, hyponatremia, dizziness, disturbance in gait and coordination, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, somnolence, fatigue, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, diplopia, blurred vision, impaired vision, hazardous activities, status epilepticus, jaundice, liver injury, abnormal T' values."
130,DUAVEE,adverse reactions,"Cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, death, venous thromboembolism (deep venous thrombosis, pulmonary embolism, retinal vein thrombosis)."
131,DUAVEE,boxed warnings,"Endometrial cancer, cardiovascular disorders, dementia, stroke, deep vein thrombosis (DVT), blood clots, breast cancer, ovarian cancer, gallbladder problems, high blood pressure, increased fats in the blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of the mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, porphyria, lupus, death."
132,DUAVEE,warnings and precautions,"Venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, coronary heart disease (CHD), endometrial cancer, breast cancer, ovarian cancer, dementia, gallbladder disease, retinal vascular thrombosis, fluid retention, hypocalcemia, hypoparathyroidism, hereditary angioedema, asthma, diabetes mellitus, epilepsy, migraine, systemic lupus erythematosus, hepatic hemangiomas, porphyria, death."
133,KALYDECO,adverse reactions,"Headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, abdominal pain, increased hepatic enzymes, hypoglycemia, headache, upper respiratory tract infection, nasal congestion, nausea, rash, rhinitis, dizziness, arthralgia, bacteria in sputum, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, hepatic enzyme increased, arthralgia, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, death."
134,KALYDECO,warnings and precautions,"Elevated transaminases (ALT or AST), transaminase elevations, increased transaminase levels, liver function tests, death, use with CYP3A inducers, diminished effectiveness, cataracts, non-congenital lens opacities, lens opacities, pediatric patients, baseline and follow-up examinations, corticosteroid use, radiation exposure."
135,AMYVID,adverse reactions,"Headache, musculoskeletal pain, increased blood pressure, nausea, fatigue, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain"
136,AMYVID,warnings and precautions,"Image misinterpretation, false negatives, extensive brain atrophy, motion artifacts, radiation risk, long-term cumulative radiation exposure, cancer."
137,TIVICAY,adverse reactions,"Insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, elevated ALT, AST, hyperglycemia, elevated lipase, neutropenia, death."
138,TIVICAY,warnings and precautions,"Hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, life-threatening reaction, hepatitis, immune reconstitution syndrome, transaminase elevations, worsening hepatitis, hepatitis B reactivation, redistribution/accumulation of body fat, obesity, buffalo hump, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death."
139,ULESFIA,adverse reactions,"Ocular irritation, application site irritation, application site anesthesia and hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, death."
140,ULESFIA,warnings and precautions,"Gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis, allergic dermatitis, irritant dermatitis, death."
141,JUBLIA,adverse reactions,"Ingrown toenails, application site dermatitis, application site vesicles, application site pain, skin irritation, blisters"
142,TRULICITY,adverse reactions,"Thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, heart rate increase, sinus tachycardia, death (in case of hypersensitivity reactions, hypoglycemia, and renal impairment)."
143,TRULICITY,boxed warnings,"Thyroid C-cell tumors, medullary thyroid carcinoma (MTC), thyroid tumors, mass in the neck, dysphagia, dyspnea, persistent hoarseness, death."
144,TRULICITY,warnings and precautions,"Thyroid C-cell tumors, medullary thyroid carcinoma, thyroid adenomas, thyroid carcinomas, pancreatitis, hypoglycemia, hypersensitivity reactions, acute renal failure, worsening of chronic renal failure, severe gastrointestinal disease, death."
145,TEFLARO,adverse reactions,"Diarrhea, nausea, rash, increased transaminases, hypokalemia, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, agranulocytosis, death."
146,TEFLARO,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, serious skin reactions, Clostridium difficile-associated diarrhea (CDAD), diarrhea, fatal colitis, anemia, drug-induced hemolytic anemia, death, development of drug-resistant bacteria."
147,JARDIANCE,adverse reactions,"Hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), death, hypovolemia, dehydration, blood pressure decreased, syncope, orthostatic hypotension, nocturia, polyuria, pollakiuria, increased creatinine, decreased eGFR, renal impairment, nausea, thirst, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, balanoposthitis, balanitis, genital infections fungal, genitourinary tract infection, balanitis candida, scrotal abscess, penile infection, phimosis."
148,JARDIANCE,warnings and precautions,"Hypotension, intravascular volume contraction, renal impairment, impaired renal function, increased serum creatinine, decreased eGFR, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), death."
149,ULORIC,adverse reactions,"Liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure, jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, death."
150,ULORIC,warnings and precautions,"Gout flare, increase in gout flares, reduction in serum uric acid levels, mobilization of urate from tissue deposits, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, liver injury, liver injury detection, fatal and non-fatal hepatic failure, transaminase elevations, serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total bilirubin, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, drug-induced liver injury, death."
151,KYPROLIS,adverse reactions,"Anemia, fatigue, thrombocytopenia, nausea, pyrexia, decreased platelets, dyspnea, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, hypokalemia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal impairment, pulmonary embolism, pulmonary edema, deep vein thrombosis, hypotension, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, tumor lysis syndrome, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, decreased platelets, decreased total white blood cell count, decreased hemoglobin, decreased potassium, death."
152,KYPROLIS,warnings and precautions,"Cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, acute renal failure, renal insufficiency, tumor lysis syndrome, pulmonary toxicity, acute respiratory distress syndrome, acute respiratory failure, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, deep venous thrombosis, pulmonary embolism, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity, death."
153,YERVOY,adverse reactions,"Immune-mediated enterocolitis, diarrhea, colitis, immune-mediated hepatitis, immune-mediated dermatitis, pruritus, rash, fatigue, immune-mediated neuropathies, immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, death, skin and subcutaneous tissue disorders, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)."
154,YERVOY,boxed warnings,"Enterocolitis, hepatitis, dermatitis (including toxic epidermal necrolysis), neuropathy, endocrinopathy, death"
155,YERVOY,warnings and precautions,"severe, life-threatening, or fatal enterocolitis, intestinal perforation, diarrhea, abdominal pain, mucus or blood in stool, fever, ileus, peritoneal signs, hepatotoxicity, AST or ALT elevations, total bilirubin elevations, liver function test abnormalities, immune-mediated hepatitis, hepatic failure, hospitalization, dermatitis, Stevens-Johnson syndrome"
156,GADAVIST,adverse reactions,"Headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash (includes generalized, macular, papular, pruritic), pruritus, erythema, hypersensitivity/anaphylactoid (including hypotension, urticaria, face edema, eyelid edema, flushing, hypotension, urticaria, face edema, eyelid edema, flushing, hypotension, urticaria, face edema, eyelid edema, flushing), dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, nephrogenic systemic fibrosis, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death."
157,GADAVIST,boxed warnings,"Nephrogenic systemic fibrosis (NSF), chronic kidney disease, severe kidney disease, acute kidney injury, reduced renal function, death."
158,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis (NSF), death, acute kidney injury, hypersensitivity reactions (anaphylactic, cardiovascular, respiratory, cutaneous manifestations), moderate irritation, overestimation of extent of malignant disease in MRI of the breast."
159,OTEZLA,adverse reactions,"Diarrhea, nausea, headache, upper respiratory tract infection, vomiting, nasopharyngitis, abdominal pain upper, abdominal pain, fatigue, dyspepsia, decrease appetite, insomnia, back pain, migraine, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, death."
160,OTEZLA,warnings and precautions,"Depression, depressed mood, suicidal thoughts, suicidal behavior, weight decrease, loss of efficacy, unexplained or clinically significant weight loss, OTEZLA should be discontinued, co-administration of strong cytochrome P450 enzyme inducer (e.g., rifampin, phenobarbital, carbamazepine, phenytoin) with OTEZLA is not recommended, loss of efficacy, death."
161,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Muscular weakness, Dry mouth, Injection site discomfort, Fatigue, Headache, Neck pain, Musculoskeletal pain, Dysphonia, Injection site pain, Eye disorders, Nasopharyngitis, Upper respiratory tract infection, Eyelid edema, Eyelid ptosis, Sinusitis, Nausea, Urinary tract infection, Dysphagia, Dizziness, Muscle atrophy, Breathing difficulty, Blood present in urine, Headache, Death."
162,DYSPORT,boxed warnings,"Asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, swallowing difficulties."
163,DYSPORT,warnings and precautions,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, swallowing difficulties, speech difficulties, death, severe dysphagia, respiratory compromise, feeding tube, aspiration, respiratory disorders, respiratory failure, surgical alterations to facial anatomy, excessive weakness or atrophy in the target muscle(s), marked facial asymmetry, inflammation at the injection site(s), ptosis, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, viral diseases, Creutzfeldt-Jakob disease, intradermal immune reaction."
164,FIRAZYR,adverse reactions,"Injection site reactions, pyrexia, transaminase increase, dizziness, rash, death"
165,FIRAZYR,warnings and precautions,"Laryngeal attacks, airway obstruction, death."
166,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Fatigue, Loss of strength or energy, Pancreatitis, Photosensitivity-related adverse reactions, Volume depletion-related adverse reactions, Falls, Significant renal function decline, Renal-related adverse reactions, Death."
167,INVOKANA,warnings and precautions,"Hypotension, renal impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increases in low-density lipoprotein (LDL-C), death."
168,XTANDI,adverse reactions,"Asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, seizure, asthenic conditions, peripheral edema, musculoskeletal pain, muscular weakness, musculoskeletal stiffness, diarrhea, hot flush, hypertension, headache, dizziness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, insomnia, anxiety, hematuria, non-pathological fracture, decreased appetite, weight decreased, gynecomastia, neutropenia, thrombocytopenia, ALT increased, bilirubin increased, infection, sepsis, fall-related injuries, hypertension, death."
169,XTANDI,warnings and precautions,"Seizure, death"
170,AFINITOR,adverse reactions,"Stomatitis, infections, rash, fatigue, diarrhea, decreased appetite, gastrointestinal disorders, dysgeusia, headache, insomnia, cough, dyspnea, epistaxis, pneumonitis, skin and subcutaneous tissue disorders, hot flush, hyperglycemia, hypercholesterolemia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), decreased hemoglobin, leukopenia, lymphopenia, neutropenia, thrombocytopenia, decreased potassium, creatinine increased, alkaline phosphatase increased, bicarbonate decreased, hypophosphatemia, increased aspartate transaminase (AST), potassium decreased, thrombotic events, renal failure, death."
171,AFINITOR,warnings and precautions,"Non-infectious pneumonitis, infections (including pneumonia, mycobacterial infections, other bacterial infections, invasive fungal infections, viral infections including hepatitis B virus), angioedema, oral ulceration, renal failure, wound-related complications, death, increased risk of infection, hypoxia, pleural effusion, cough, dyspnea, radiological changes, fever, fatigue, nausea, vomiting, diarrhea, abdominal pain, anorexia, headache, dizziness, rash, pruritus, alopecia, hyperglycemia, hypercholesterolemia, hypertriglyceridemia, decreased hemoglobin, decreased lymphocytes, decreased neutrophils, decreased platelets, increased BUN, increased serum creatinine, increased urinary protein, increased lipids, increased glucose, embryo-fetal toxicity, death."
172,ENTEREG,adverse reactions,"Dyspepsia, increased severity of events present at baseline"
173,ENTEREG,boxed warnings,"Myocardial infarction, heart attack, death"
174,ENTEREG,warnings and precautions,"Myocardial infarction, abdominal pain, nausea, vomiting, diarrhea, death"
175,COARTEM,adverse reactions,"Headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, diarrhea, nausea, abdominal pain, fatigue, malaria, chills, palpitations, hepatomegaly, splenomegaly, anemia, rhinitis, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, eosinophilia, impetigo, influenza, lymphocyte morphology abnormal, proteinuria, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, pharyngo-laryngeal pain, anaphylaxis, urticaria, angioedema, serious skin reactions (bullous eruption), death."
176,COARTEM,warnings and precautions,"QT prolongation, cardiac arrhythmias, bradycardia, severe cardiac disease, hypokalemia, hypomagnesemia, death, additive effects on the QT interval, limited safety data, decreased efficacy, food consumption, loss of antimalarial efficacy, plasma concentrations, adverse effects, QT interval, recrudescence, hepatic impairment, renal impairment, erythrocytic stage, radical cure, hypnozoites forms."
177,DALVANCE,adverse reactions,"Nausea, headache, diarrhea, vomiting, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, death (if there was a fatal event related to these adverse reactions)."
178,DALVANCE,warnings and precautions,"Hypersensitivity reactions (anaphylactic, skin), infusion-related reactions (flushing, urticaria, pruritus, rash), ALT elevations, Clostridium difficile-associated diarrhea, diarrhea, fatal colitis, drug-resistant bacteria."
179,FERRIPROX,adverse reactions,"Chromaturia, nausea, vomiting, abdominal pain, arthralgia, neutropenia, agranulocytosis, alanine aminotransferase increased, diarrhea, dyspepsia, weight increased, decreased appetite, back pain, pain in extremity, arthropathy, headache, increased appetite, aspargate aminotransferase increased, neutrophil count decreased, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death."
180,FERRIPROX,boxed warnings,"Agranulocytosis, neutropenia, serious infections, death, infection"
181,FERRIPROX,warnings and precautions,"Agranulocytosis, neutropenia, death, infection, fetal harm, embryofetal death, malformations, increased ALT values, increased serum transaminase levels."
182,PRADAXA,adverse reactions,"Bleeding, gastritis-like symptoms, dyspepsia, abdominal pain upper, abdominal pain, abdominal discomfort, epigastric discomfort, gastritis, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, gastrointestinal bleeding, gastric symptoms, anaphylactic reaction, anaphylactic shock, angioedema, thrombocytopenia, esophageal ulcer, death."
183,PRADAXA,boxed warnings,"Thrombotic events, spinal/epidural hematoma, death"
184,PRADAXA,warnings and precautions,"Bleeding, blood loss, pathological bleeding, thrombotic events, midline back pain, sensory and motor deficits, bowel and/or bladder dysfunction, death, spinal hematoma, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, post-operative pericardial effusions, hemodynamic compromise, contraindicated, bioprosthetic heart valves, renal impairment, increased exposure to dabigatran, skin necrosis, infection of the skin and subcutaneous tissue, fatal outcomes, epidermal necrolysis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms."
185,VORAXAZE,adverse reactions,"Paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, death"
186,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions, death."
187,HORIZANT,adverse reactions,"Somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, blurred vision, disorientation, balance disorder, vertigo, lethargy, depression, insomnia, libido decreased, asthenia, breast enlargement, gynecomastia, elevated creatine kinase, death."
188,HORIZANT,warnings and precautions,"Driving impairment, somnolence/sedation, dizziness, death, suicidal thoughts or behaviors, depression, suicidal thoughts or behavior, untreated illness, morbidity, mortality, tumorigenic potential, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, new tumors, worsening of preexisting tumors, oral carcinogenicity."
189,STENDRA,adverse reactions,"Headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, death (in case of non-arteritic anterior ischemic optic neuropathy)."
190,STENDRA,warnings and precautions,"Hypotension, prolonged erection (erection lasting greater than 4 hours, priapism), sudden loss of vision, sudden decrease or loss of hearing, death, cardiovascular risks, hemodynamic instability, orthostatic signs and symptoms, bleeding disorders, peptic ulceration, sexually transmitted diseases."
191,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), JC virus infection, death"
192,ADCETRIS,warnings and precautions,"Peripheral neuropathy, anaphylaxis, infusion reactions, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, severe hepatic impairment, hepatotoxicity, hepatocellular injury, progressive multifocal leukoencephalopathy (PML), pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), dermatologic reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), death, fetal harm, embryo-fetal toxicities, fetal malformations, decreased embryo viability."
193,ZERBAXA,adverse reactions,"Nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, increased ALT, increased AST, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, renal impairment, renal failure, dyspnea, urticaria, venous thrombosis, death."
194,ZERBAXA,warnings and precautions,"Decreased efficacy, renal function impairment, hypersensitivity reactions, anaphylactic reactions, serous reactions, fatal reactions, diarrhea, Clostridium difficile-associated diarrhea (CDAD), drug-resistant bacteria."
195,ZYDELIG,adverse reactions,"Hepatotoxicity, severe diarrhea or colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, death, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, neutrophil count decreased, lymphocyte count decreased, lymphocyte count increased, ALT increased, AST increased, GGT increased, triglycerides increased, hyperglycemia, hyponatremia."
196,ZYDELIG,boxed warnings,"Hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death."
197,ZYDELIG,warnings and precautions,"Severe cutaneous reactions, anaphylaxis, neutropenia, death, hepatotoxicity, diarrhea, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), rash, dermatitis exfoliative, skin disorder, fetal harm, teratogenic."
198,SIMPONI,adverse reactions,"Serious infections, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, malignancies, lymphoma, non-melanoma skin cancer (NMSC), liver enzyme elevations, acute liver failure, autoimmune disorders, autoantibodies, lupus-like syndrome, infusion reactions, antibodies to Simponi Aria, neutralizing antibodies, pyrexia, leukopenia, superficial fungal infection, sinusitis, abscess, lower respiratory tract infection, pneumonia, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, death."
199,SIMPONI,boxed warnings,"Serious infections, tuberculosis, bacterial sepsis, invasive fungal such as histoplasmosis, and other opportunistic infections, sepsis, tuberculosis (TB), histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial, viral, and other infections due to opportunistic pathogens, lymphoma, malignancy, death."
200,SIMPONI,warnings and precautions,"Serious infections, invasive fungal infections, hepatitis B reactivation, malignancies (lymphoma, leukemia, hepatosplenic T-cell lymphoma, melanoma, Merkel cell carcinoma), congestive heart failure, central nervous system demyelinating disorders, worsening congestive heart failure, new onset congestive heart failure, demyelinating disorders, death."
201,BLINCYTO,adverse reactions,"Pyrexia, headache, peripheral edema, febrile neutropenia, nausea, hypokalemia, constipation, febrile neutropenia, anemia, neutropenia, thrombocytopenia, leukopenia, nausea, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, pneumonia, sepsis, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypokalemia, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, bone pain, headache, tremor, insomnia, cough, dyspnea, rash, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, death."
202,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), life-threatening, fatal, Neurological toxicities, severe, life-threatening, fatal, interrupt, discontinue."
203,BLINCYTO,warnings and precautions,"Cytokine Release Syndrome (CRS), pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, serious infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome (TLS), neutropenia, febrile neutropenia, death, effects on ability to drive and use machines, seizures, elevated liver enzymes, leukoencephalopathy, medication errors, underdose, overdose."
204,NATAZIA,adverse reactions,"death, myocardial infarction, deep vein thrombosis, cerebral thrombosis, pulmonary emboli, hypertension, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, venous and arterial thromboembolic events, headache (including migraines), breast pain, discomfort or tenderness, menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage), nausea or vomiting, acne, mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying), increased weight, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), vaginal hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms (for example, abdominal pain), vulvovaginal candidiasis."
205,NATAZIA,boxed warnings,"serious cardiovascular events, death"
206,NATAZIA,warnings and precautions,"Thrombotic events, venous thromboembolism, arterial thromboses such as strokes and myocardial infarctions, retinal vein thrombosis, jaundice, hepatic adenomas, hepatocellular carcinoma, cholestasis, hypertension, gallbladder disease, decreased glucose tolerance, uncontrolled dyslipidemia, hypertriglyceridemia, pancreatitis, headache including migraine and cerebrovascular events, bleeding irregularities including breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, birth defects, depression, interference with laboratory tests including coagulation factors, lipids, glucose tolerance, and binding proteins, drug interactions including with strong cytochrome P450 3A4 (CYP3A4) inducers such as carbamazepine, phenytoin, rifampicin, and St. John's wort, angioedema, chloasma, death."
207,DIFICID,adverse reactions,"Nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, vomiting, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, hypersensitivity reactions (dyspnea, angioedema, rash, and pruritus)"
208,DIFICID,warnings and precautions,"Hypersensitivity reactions, dyspnea, rash, pruritus, angioedema, death, drug-resistant bacteria."
209,EDARBI,adverse reactions,"Diarrhea, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increase, low hemoglobin, low hematocrit, low RBC counts, low and high markedly abnormal platelet and WBC counts, rash, pruritus, angioedema, death."
210,EDARBI,boxed warnings,"Fetal toxicity, injury, death, pregnancy, pregnancy detection."
211,EDARBI,warnings and precautions,"Hypotension, fetal toxicity, oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, hypotension, renal failure, death, impaired renal function, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen."
212,IMBRUVICA,adverse reactions,"Thrombocytopenia, diarrhea, neutropenia, anemia, fatigue, musculoskeletal pain, peripheral edema, upper respiratory tract infection, nausea, bruising, dyspnea, constipation, vomiting, decreased appetite, abdominal pain, pyrexia, urinary tract infection, pneumonia, skin infections, sinusitis, stomatitis, dyspepsia, epistaxis, dehydration, dizziness, headache, musculoskeletal pain, arthralgia, muscle spasms, oropharyngeal pain, peripheral neuropathy, hypertension, anxiety, insomnia, laceration, second malignancies, hemorrhage, infections, subdural hematomas, renal failure, hyperuricemia, tumor lysis syndrome, death."
213,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, fever, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, cardiac risk factors, acute infections, previous history of atrial fibrillation, arrhythmic symptoms, palpitations, lightheadedness, ECG, dyspnea, dose modification, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, fetal harm, malformations, reduced fetal weights, pregnancy, animal findings"
214,DUREZOL,adverse reactions,"Elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, death, blurred vision, headache, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, corneal edema, dry eye, iridocyclitis, photophobia, reduced visual acuity."
215,DUREZOL,warnings and precautions,"IOP increase, glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, perforations, thinning of the cornea or sclera, increased hazard of secondary ocular infections, suppressed host response, acute purulent conditions, mask infection, enhance existing infection, viral infections, herpes simplex, fungal infections, cornea ulceration, fungus invasion, topical ophthalmic use, contact lens wear"
216,ZYKADIA,adverse reactions,"Diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, increased ALT, increased AST, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, hyperglycemia, neuropathy, vision disorder, prolonged QT interval, bradycardia, decreased hemoglobin, decreased phosphate, increased creatinine, increased glucose, increased lipase, increased bilirubin, death."
217,ZYKADIA,warnings and precautions,"Severe or Persistent Gastrointestinal Toxicity (diarrhea, nausea, vomiting, abdominal pain), hepatotoxicity, Interstitial Lung Disease (ILD)/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, death, embryofetal toxicity."
218,CHOLINE,adverse reactions,"uncommon, mild injection site reaction"
219,CHOLINE,warnings and precautions,"Imaging errors, poor imaging performance, false positive results, false negative results, higher numbers of false positive and false negative results, tissue inflammation, prostatic hyperplasia, concomitant colchicine, androgen-deprivation therapeutic drugs, discontinuation of colchicine, discontinuation of androgen-deprivation therapy, allergic reactions, anaphylaxis, radiation risk, long-term cumulative radiation exposure, increased risk for cancer, safe handling, death."
220,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis, Hemorrhage, Hyperglycemia, Transaminases abnormal, Fever, Local reactions, Hyperbilirubinemia, Abdominal pain/discomfort, Diarrhea, Allergic reactions, Hemorrhage, Thrombosis or infarct, Hyperbilirubinemia, Hyperglycemia, Hyperlipidemia, Ketoacidosis, CNS events (hemorrhage, thrombosis or infarction, and cerebral venous thrombosis), Thrombotic events, Hemorrhagic events, Hepatobiliary disorders, Pancreatic disorders, Death"
221,ERWINAZE,warnings and precautions,"Hypersensitivity reactions, serious, anaphylaxis, pancreatitis, severe, hemorrhagic, glucose intolerance, thrombosis, hemorrhage, death."
222,SAPHRIS,adverse reactions,"akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, somnolence, oral hypoesthesia, dry mouth, dyspepsia, headache, arthralgia, pain in extremity, depression, insomnia, anxiety, dysgeusia, dyspnea, vomiting, hyperhidrosis, irritability, muscle rigidity, parkinsonism, gait disturbance, masked facies, tremor, hypertension, decreased appetite, abdominal pain, nausea, toothache, pain, agitation, akinesia, anxiety symptoms, confusion, hostility, hyperkinesia, lethargy, nervousness, paranoid reaction, psychotic depression, restlessness, sleep disorder, suicide ideation, syncope, tachycardia, vasodilatation, decreased blood pressure, hypertonia, hypotension, myalgia, neck pain, orthostatic hypotension, pain in jaw, photosensitivity reaction, short QT syndrome, substance withdrawal syndrome, vertigo, visual disturbance, diarrhea, dry mouth, dysmenorrhea, dyspepsia, eructation, fecaloma, flatulence, gastroesophageal reflux disease, gastrointestinal discomfort, gastrointestinal pain, hyperchlorhydria, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypoglycemia, hypokalemia, hyponatremia, increased alkaline phosphatase, increased amylase, increased bilirubin, increased creatine phosphokinase, increased eosinophils, increased gamma-glutamyltransferase, increased hematocrit, increased lactate dehydrogenase, increased neutrophils, increased non-protein nitrogen, increased prothrombin time, increased uric acid, leukocytosis, leukopenia, lymphocytosis, lymphopenia, monocytosis, proteinuria, thrombocythemia, thrombocytopenia, thrombocytosis, weight decreased, weight increased, anemia, neutropenia, pancytopenia, abnormal dreams, agitation, amnesia, anxiety, apathy, catatonia, cognitive disorder, confusional state, delirium, delusion, dementia, depression, dysarthria, emotional lability, excitation, hallucination, mania, neuroleptic malignant syndrome, obsessive-compulsive disorder, panic attack, phobic disorder, psychosis, sleep disorder, suicide attempt, thinking abnormal, amnesia, anxiety symptoms, confusion, delirium, depression, emotional lability, excitation, hallucination, hostility, insomnia, mania, neuroleptic malignant syndrome, obsessive-compulsive disorder, panic attack, phobic disorder, psychosis, sleep disorder, suicide attempt, thinking abnormal, abnormal electrocardiogram, abnormal hepatic function, abnormal liver function test, abnormal renal function, abnormal urine, alopecia, angioedema, anxiety, asthenia, back pain, bradycardia, chills, constipation, creatine phosphokinase increased, decreased appetite, decreased libido, diarrhea, diplopia, dizziness, dry mouth, dysarthria, dysgeusia, dysmenorrhea, dyspnea, ear pain, ecchymosis, emotional lability, eye pain, face edema, fall, feeling abnormal, flushing, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gastrointestinal pain, hyperacusis, hyperhidrosis, hyperkinesia, hyperlipidemia, hypertonia, hypersensitivity, hypesthesia, hypoglycemia, hypokalemia, hyponatremia, hypotension, hypoxia, infection, injection site reaction, insomnia, intestinal obstruction, leukocytosis, leukopenia, malaise, migraine, myalgia, neck pain, neuralgia, neutropenia, orthostatic hypotension, pain, pain in jaw, palpitations, paresthesia, pharyngitis, photosensitivity reaction, rash, respiratory disorder, restlessness, rhinitis, sinus headache, skin discoloration, speech disorder, stupor, sweating, syncope, tachycardia, thirst, tooth disorder, urinary retention, urticaria, vasodilatation, visual disturbance, weakness, xerostomia."
223,SAPHRIS,boxed warnings,"Increased mortality, death, dementia-related psychosis"
224,SAPHRIS,warnings and precautions,"Cerebrovascular adverse events (e.g., stroke, transient ischemic attack), Neuroleptic Malignant Syndrome, Tardive Dyskinesia, metabolic changes (including hyperglycemia, dyslipidemia, and weight gain), hypersensitivity reactions (including anaphylaxis and angioedema), orthostatic hypotension, syncope, hemodynamic effects (dizziness, tachycardia or bradycardia), leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive and motor impairment, suicide, increased mortality in elderly patients with dementia-related psychosis, hyperglycemia, diabetes mellitus, dyslipidemia, body weight gain, hyperosmolar coma, ketoacidosis, death, worsening of glucose control, polydipsia, polyuria, polyphagia, weakness, and rhabdomyolysis."
225,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, influenza, pneumonia, asthenia, hyperhidrosis, dysgeusia, asthenia, hyperhidrosis, anorexia, hemoglobin decreased, weight decreased."
226,CARBAGLU,warnings and precautions,"Hyperammonemia, brain injury/damage, death, dialysis, hemodialysis, life-threatening emergency, plasma ammonia levels, normal range for age, individual dose adjustment, protein restriction, caloric supplementation, catabolism, nitrogen turnover."
227,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, headache, hyperbilirubinemia, ALT increased, AST increased, fatigue, vitamin D deficiency, anemia, pyrexia, asthenia, insomnia, cough, pruritus, chills, myalgia, alopecia, peripheral edema, abdominal pain, toothache, diarrhea, Rash, vitamin D deficiency, anemia, pyrexia, fatigue, headache, nausea, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, myalgia, alopecia, peripheral edema, hyperbilirubinemia, total bilirubin greater than or equal to 1.5 x ULN, ALT or AST greater than or equal to 3 x ULN, nausea, fatigue, cough, diarrhea, headache, pain in extremity, dyspnea, pyrexia, dizziness, oropharyngeal pain, febrile neutropenia, abdominal pain, ecchymosis, death."
228,PROMACTA,boxed warnings,"Hepatic decompensation, death"
229,PROMACTA,warnings and precautions,"hepatic decompensation, hepatotoxicity, liver enzyme elevations, indirect hyperbilirubinemia, abnormal serum liver tests, liver injury, thrombotic events, venous and arterial events, thromboembolism, risk factors for thromboembolism (e.g., Factor V Leiden, ATIII deficiency, antiphospholipid syndrome, chronic liver disease), portal venous system, abdominal pain, nausea, vomiting, diarrhea, cataracts"
230,BESIVANCE,adverse reactions,"Conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache, death."
231,BESIVANCE,warnings and precautions,"Bacterial conjunctivitis, overgrowth of non-susceptible organisms, fungi, super-infection, death."
232,INLYTA,adverse reactions,"hypertension, blood pressure increased, diarrhea, loose stools, fatigue, asthenia, decreased appetite, anorexia, nausea, vomiting, dysphonia, palmar-plantar erythrodysesthesia, palmar-plantar erythrodysesthesia syndrome, hand-foot syndrome, weight decreased, weight loss, vomiting, regurgitation, asthenia, weakness, constipation, difficulty defecating, hypothyroidism, decreased thyroid function, decreased appetite, anorexia, cough, coughing, mucosal inflammation, mucositis, arthralgia, joint pain, stomatitis, mouth inflammation, dyspnea, shortness of breath, abdominal pain, abdominal discomfort, headache, head pain, pain in extremity, limb pain, rash, erythema, proteinuria, protein in urine, dysgeusia, taste disturbance, dry skin, xerosis, dyspepsia, indigestion, pruritus, itching, alkaline phosphatase increased, ALP increased, alanine aminotransferase increased, ALT increased, aspartate aminotransferase increased, AST increased, creatinine increased, renal dysfunction, bicarbonate decreased, acidemia, hypocalcemia, low calcium, hypoglycemia, low blood sugar, hypernatremia, high sodium, hypoalbuminemia, low albumin, hyperkalemia, high potassium, hyponatremia, low sodium, hypophosphatemia, low phosphate, hemoglobin decreased, anemia, lymphocytes decreased, lymphopenia, platelets decreased, thrombocytopenia, white blood cells decreased, leukopenia, anemia, hemorrhoids, piles, hematuria, blood in urine, tinnitus, ringing in ears, lipase increased, lipase elevated, glossodynia, tongue pain, pulmonary embolism, lung blood clot, rectal hemorrhage, rectal bleeding, hemoptysis, coughing up blood, deep vein thrombosis, deep vein thrombosis, retinal-vein occlusion/thrombosis, retinal vein occlusion, polycythemia, high red blood cell count, transient ischemic attack, mini-stroke, dehydration, dehydration, epistaxis, nosebleed, myalgia, muscle pain, death"
233,INLYTA,warnings and precautions,"Hypertension, hypertensive crisis, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, elevation of liver enzymes, hepatic impairment, fetal harm, hypertensive crisis, arterial thromboembolic events (cerebrovascular accident), venous thromboembolic events (pulmonary embolism), hemorrhage (gastric hemorrhage), cardiac failure, gastrointestinal perforation, RPLS, hepatic impairment."
234,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, Headache, Dizziness, Nausea, Hypertension, Fatigue, Death, Falls, Urinary Tract Infections, Syncope"
235,NORTHERA,boxed warnings,"supine hypertension, elevated blood pressure in the supine position, increased blood pressure while lying down, severe consequences, death"
236,NORTHERA,warnings and precautions,"Supine hypertension, cardiovascular risk, hyperpyrexia, confusion, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, ischemic heart disease, arrhythmias, congestive heart failure, death, allergic reactions, bronchial asthma, FD&C Yellow No. 5 (tartrazine) sensitivity."
237,ADREVIEW,all-concat,"Hypersensitivity reactions, dizziness, rash, pruritus, flushing, injection site hemorrhage, hematoma, bruising, headache, hypertension, thyroid neoplasia, benzyl alcohol toxicity, metabolic acidosis, kernicterus, death."
238,AFINITOR,all-concat,"Stomatitis, infections, rash, fatigue, diarrhea, decreased appetite, gastrointestinal disorders, dysgeusia, headache, insomnia, cough, dyspnea, epistaxis, pneumonitis, skin and subcutaneous tissue disorders, hot flush, hyperglycemia, hypercholesterolemia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), decreased hemoglobin, leukopenia, lymphopenia, neutropenia, thrombocytopenia, decreased potassium, creatinine increased, alkaline phosphatase increased, bicarbonate decreased, hypophosphatemia, increased aspartate transaminase (AST), potassium decreased, thrombotic events, renal failure, death."
239,AMPYRA,all-concat,"Urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, death (due to seizures)"
240,AMYVID,all-concat,"Headache, musculoskeletal pain, increased blood pressure, hypertension, nausea, fatigue, injection site reaction, injection site hemorrhage, injection site irritation, injection site pain, feeling cold, chills, anxiety, back pain, claustrophobia, dizziness, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing, death."
241,APTIOM,all-concat,"Suicidal behavior and ideation, Serious dermatologic reactions including Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic reactions and angioedema, Hyponatremia, Neurological adverse reactions including dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, and visual changes, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, Decreases in hemoglobin and hematocrit, Increases in total cholesterol, triglycerides, and LDL, Increases in creatine phosphokinase, Hypertension, Rash, Withdrawal of APTIOM, Death"
242,ARCAPTA,all-concat,"Asthma-related death, Cough, Oropharyngeal pain, Nasopharyngitis, Headache, Nausea, Musculoskeletal pain, Peripheral edema, Diabetes mellitus, Hyperglycemia, Sinusitis, Upper respiratory tract infection, Hypersensitivity reactions, Paradoxical bronchospasm, Tachycardia/heart rate increase/palpitations, Pruritus/rash, Dizziness"
243,BELEODAQ,all-concat,"Hematologic Toxicity, anemia, thrombocytopenia, leukopenia (neutropenia and lymphopenia), infection, pneumonia, sepsis, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, vomiting, diarrhea, embryo-fetal toxicity, death."
244,BENLYSTA,all-concat,"nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, depression, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, anaphylaxis, death"
245,BEPREVE,all-concat,"Mild taste following instillation, eye irritation, headache, nasopharyngitis, itching, body rash, swelling of lips, tongue and/or throat, contamination of tip and solution, contact lens-related irritation, red eye"
246,BESIVANCE,all-concat,"Conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache, death"
247,BLINCYTO,all-concat,"Cytokine Release Syndrome, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome, neutropenia, febrile neutropenia, effects on ability to drive and use machines, elevated liver enzymes, death."
248,BOSULIF,all-concat,"Gastrointestinal toxicity (includes diarrhea, nausea, vomiting, abdominal pain), Myelosuppression (includes thrombocytopenia, anemia, neutropenia), Hepatic toxicity (includes increased ALT or AST, drug-induced liver injury), Fluid retention (includes pericardial effusion, pleural effusion, pulmonary edema, peripheral edema), Renal toxicity, Anaphylactic shock, Rash, Fatigue, Pyrexia, Increased alanine aminotransferase (ALT) or aspartate aminotransferase (AST), Headache, Cough, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval prolongation, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Anaphylactic shock, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Pruritus, Acne, Erythema multiforme, Exfoliative rash, Drug eruption, Death"
249,BREO,all-concat,"asthma-related death, asthma-related hospitalization, asthma-related deaths, increased risk of pneumonia in COPD, immunosuppression, hypercorticism and adrenal suppression, reduction in bone mineral density, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism and adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, headache, nasopharyngitis, influenza, upper respiratory tract infection, sinusitis, bronchitis, cough, oropharyngeal pain, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, upper respiratory tract infection, headache, oropharyngeal candidiasis, nasopharyngitis, oral candidiasis, headache, influenza, upper respiratory tract infection, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough."
250,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, asthenia, hyperhidrosis, influenza, pneumonia, dysgeusia, anorexia, somnolence, rash, death (from hyperammonemia)."
251,CERDELGA,all-concat,"Fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, cardiac arrhythmias, long QT syndrome, congestive heart failure, recent acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, QTc interval prolongation, QRS cardiac interval prolongation, PR interval prolongation."
252,CHOLINE,all-concat,"Injection site reaction, blood PSA levels < 2 ng/ML, poor imaging performance, false positive, false negative, tissue inflammation, prostatic hyperplasia, imaging errors, recurrent prostate cancer, lung carcinoma, brain tumors, radiation risk, long-term cumulative radiation exposure, cancer, anaphylaxis, death."
253,CIMZIA,all-concat,"Upper respiratory tract infection, rash, urinary tract infection, abdominal pain, diarrhea, intestinal obstruction, pyrexia, urticaria, pneumonia, menstrual disorder, thrombophlebitis, vasculitis, hypertensive adverse reactions, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, acute bronchitis, fatigue, back pain, headache."
254,CLEVIPREX,all-concat,"Hypotension, Reflex tachycardia, Headache, Nausea, Vomiting, Acute renal failure, Atrial fibrillation, Myocardial infarction, Cardiac arrest, Syncope, Dyspnea, Increased blood triglycerides, Ileus, Hypersensitivity, Decreased oxygen saturation (possible pulmonary shunting), Rebound hypertension"
255,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, chills, fatigue, malaise, nausea, vomiting, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, cough, pruritus, rash, vertigo, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, nasopharyngitis, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, anaphylaxis, urticaria, angioedema, serious skin reactions (bullous eruption), congenital prolongation of the QT interval, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, family history of congenital prolongation of the QT interval or sudden death, known disturbances of electrolyte balance (e.g., hypokalemia or hypomagnesemia), medications that prolong the QT interval, medications that are metabolized by the cytochrome enzyme CYP2D6 which also have cardiac effects, mefloquine, substrates of CYP3A4, inhibitors of CYP3A4 (e.g., grapefruit juice), inducers of CYP3A4, antiretroviral medications, antimalarials (quinine and quinidine), QT prolonging drugs, hormonal contraceptives, death."
256,COMETRIQ,all-concat,"Perforations, fistula, hemorrhage, thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolic events, wound complications, dehiscence, hypertension, overt hypertension, malignant hypertension, decreased weight, decreased appetite, nausea, fatigue, oral pain, diarrhea, stomatitis, vomiting, abdominal pain, constipation, dysgeusia, headache, dizziness, asthenia, arthralgia, muscle spasms, musculoskeletal chest pain, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, increased AST, increased ALT, increased ALP, hypocalcemia, hypophosphatemia, hypomagnesemia, hypokalemia, hyponatremia, lymphopenia, neutropenia, thrombocytopenia, hyperbilirubinemia, dehydration, hypotension, death."
257,DALVANCE,all-concat,"Nausea, headache, diarrhea, vomiting, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, increased hepatic transaminases, increased blood alkaline phosphatase, increased international normalized ratio, hypoglycemia, dizziness, bronchospasm, urticaria, ALT elevations, hypersensitivity reactions, skin reactions, death."
258,DATSCAN,all-concat,"Headache, nausea, vertigo, dry mouth, dizziness, hypersensitivity reactions, injection site pain, rash, pruritis, thyroid accumulation, increased long term risk for thyroid neoplasia, death."
259,DIFICID,all-concat,"Nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, hypersensitivity reactions (dyspnea, angioedema, rash, pruritus), death."
260,DOTAREM,all-concat,"Nephrogenic systemic fibrosis (NSF), death, bradycardia, tachycardia, arrhythmia, hypersensitivity/anaphylactoid reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, acute kidney injury, serum creatinine increased, injection site reactions, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort."
261,DUAVEE,all-concat,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, Muscle spasms, Nausea, Diarrhea, Dyspepsia, Abdominal pain upper, Oropharyngeal pain, Dizziness, Neck pain, Venous thromboembolism (deep venous thrombosis, pulmonary embolism, and retinal vein thrombosis), Endometrial cancer, Stroke, Deep vein thrombosis (DVT), Probable dementia, Blood clots, Hot flushes, Osteoporosis, Breast cancer, Cancer of the ovary, High blood pressure, Increased fats in your blood, Liver problems, Thyroid problems, Fluid retention, Low calcium, Swelling of your mouth or tongue, Worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus, and liver problems, Death"
262,DUREZOL,all-concat,"Elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, corneal edema, ciliary and conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, iridocyclitis, corneal edema, dry eye, increased IOP, limbal and conjunctival hyperemia, anterior chamber flare, corneal ulceration, fungal infections, delayed healing, perforations, bleb formation, suppressed host response, masking or enhancement of infection, prolonged course and severity of viral infections, glaucoma, defects in visual acuity and fields of vision, cataracts, posterior subcapsular cataract formation, herpes simplex, increased hazard of secondary ocular infections, fungal culture, topical ophthalmic use only, contact lens wear."
263,DYSPORT,all-concat,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Muscular weakness, Dry mouth, Injection site discomfort, Fatigue, Headache, Neck pain, Musculoskeletal pain, Dysphonia, Injection site pain, Eye disorders, Nasopharyngitis, Upper respiratory tract infection, Eyelid edema, Eyelid ptosis, Sinusitis, Nausea, Urinary tract infection, Dysphagia, Dizziness, Muscle atrophy, Breathing difficulty, Blood present in urine, Headache, Death."
264,EDARBI,all-concat,"Diarrhea, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increase, low hemoglobin, low hematocrit, low RBC counts, low and high markedly abnormal platelet and WBC counts, nausea, muscle spasms, rash, pruritus, angioedema, fetal toxicity, hypotension in volume- or salt-depleted patients, impaired renal function, death."
265,ELIQUIS,all-concat,"Bleeding, including intracranial bleed, gastrointestinal (GI) bleed, fatal bleeding, Hypersensitivity reactions, such as skin rash and anaphylactic reactions, Syncope, Thrombotic events after premature discontinuation, Death (fatal bleeding, intracranial bleeding, non-intracranial bleeding), Increased transaminases (alanine aminotransferase increased and alanine aminotransferase abnormal), Increased aspartate aminotransferase, Increased gamma-glutamyltransferase, Hematuria, Blood and lymphatic system disorders, such as thrombocytopenia, Vascular disorders, such as hypotension, Respiratory, thoracic, and mediastinal disorders, such as epistaxis, Gastrointestinal disorders, such as gastrointestinal hemorrhage, hematemesis, melena, and hematochezia, Hepatobiliary disorders, such as liver function test abnormal, blood alkaline phosphatase increased, and blood bilirubin increased."
266,ENTEREG,all-concat,"Dyspepsia, myocardial infarction, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions, end-stage renal disease, complete gastrointestinal obstruction, death"
267,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), hypersensitivity reactions (anaphylactic/hypersensitivity reactions with cardiovascular, respiratory and cutaneous manifestations, ranging from mild to severe reactions including shock), acute kidney injury, extravasation and injection site reactions, interference with laboratory tests, interference with visualization of liver lesions, death, tachycardia, restlessness."
268,ERWINAZE,all-concat,"Hypersensitivity reactions, anaphylaxis, pancreatitis, glucose intolerance, thrombosis, hemorrhage, death."
269,EYLEA,all-concat,"Conjunctival hemorrhage, eye pain, cataract, vitreous floaters, increased intraocular pressure, vitreous detachment, endophthalmitis, retinal detachment, retinal tear, thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, acute increases in intraocular pressure, sustained increases in intraocular pressure, death."
270,FANAPT,all-concat,"Dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, dry mouth, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, abdominal discomfort, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, cholelithiasis, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restlessness, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, retrograde ejaculation, death."
271,FARXIGA,all-concat,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Death, Female genital mycotic infections, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures."
272,FERRIPROX,all-concat,"Chromaturia, nausea, vomiting, abdominal pain, increased alanine aminotransferase, arthralgia, neutropenia, agranulocytosis, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death."
273,FIRAZYR,all-concat,"Injection site reactions, pyrexia, transaminase increase, dizziness, rash, death."
274,FULYZAQ,all-concat,"Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count, death."
275,GADAVIST,all-concat,"Headache, Nausea, Dizziness, Dysgeusia, Feeling hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, Loss of consciousness, Convulsion, Parosmia, Tachycardia, Palpitation, Dry mouth, Malaise, Feeling cold, Cardiac arrest, Nephrogenic Systemic Fibrosis (NSF), Anaphylactic shock, Circulatory collapse, Respiratory arrest, Pulmonary edema, Bronchospasm, Cyanosis, Oropharyngeal swelling, Laryngeal edema, Blood pressure increased, Chest pain, Angioedema, Conjunctivitis, Hyperhidrosis, Cough, Sneezing, Burning sensation, Pallor, Acute kidney injury, Moderate irritation, Overestimation of extent of malignant disease in MRI of the breast"
276,GILENYA,all-concat,"Bradyarrhythmia, atrioventricular blocks, infections, influenza, sinusitis, bronchitis, herpes zoster, tinea versicolor, bradycardia, headache, migraine, nausea, diarrhea, abdominal pain, asthenia, back pain, pain in extremity, alopecia, actinic keratosis, basal cell carcinoma, liver transaminase elevations, blood triglycerides increased, cough, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, ischemic and hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma, death."
277,GILOTRIF,all-concat,"Diarrhea, vomiting, nausea, stomatitis, rash/dermatitis acneiform, pruritus, dry skin, paronychia, decreased appetite, epistaxis, rhinitis, weight decreased, pyrexia, conjunctivitis, pancreatitis, dehydration, renal failure, death, bullous and blistering skin disorders, interstitial lung disease, hepatic toxicity, keratitis, embryofetal toxicity."
278,GRANIX,all-concat,"Bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, splenic rupture, acute respiratory distress syndrome (ARDS), allergic reactions (angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, and urticaria), sickle cell crisis, capillary leak syndrome, tumor growth, death."
279,HALAVEN,all-concat,"Neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, thrombocytopenia, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death."
280,HORIZANT,all-concat,"Somnolence/sedation, dizziness, fatigue/asthenia, headache, insomnia, vertigo, balance disorder, confusional state, depression, gynecomastia, breast enlargement, elevated creatine kinase, feeling drunk, feeling abnormal, disorientation, lethargy, nausea, dry mouth, flatulence, peripheral edema, blurred vision, irritability, libido decreased, depression, increased appetite, asthenia, withdrawal symptoms, driving impairment, suicidal thoughts or behavior, Death."
281,ILARIS,all-concat,"nasopharyngitis, diarrhea, influenza, headache, nausea, infections (e.g., pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis), abdominal pain (upper), rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, vertigo, injection site reactions (mild and moderate)"
282,IMBRUVICA,all-concat,"Thrombocytopenia, diarrhea, neutropenia, anemia, fatigue, musculoskeletal pain, peripheral edema, upper respiratory tract infection, nausea, bruising, dyspnea, constipation, vomiting, decreased appetite, abdominal pain, pyrexia, urinary tract infection, pneumonia, skin infections, sinusitis, stomatitis, dyspepsia, epistaxis, dehydration, dizziness, headache, musculoskeletal pain, arthralgia, muscle spasms, oropharyngeal pain, peripheral neuropathy, hypertension, anxiety, insomnia, laceration, second malignancies, hemorrhage, infections, subdural hematomas, renal failure, hyperuricemia, tumor lysis syndrome, death."
283,INLYTA,all-concat,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alkaline phosphatase (ALP) increased, alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased, creatinine increased, bicarbonate decreased, hypocalcemia, hyperglycemia, lipase increased, amylase increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, hemoglobin increased, hypercalcemia, hypertension including hypertensive crisis, arterial thromboembolic events, hemorrhagic events, cardiac failure, gastrointestinal perforation and fistula formation, thyroid dysfunction, wound healing complications, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, elevation of liver enzymes, hepatic impairment, fetal development."
284,INTELENCE,all-concat,"rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, increased pancreatic amylase, increased lipase, increased creatinine, decreased hemoglobin, decreased white blood cell count, decreased neutrophils, decreased platelet count, increased total cholesterol, increased low density lipoprotein, increased triglycerides, increased glucose levels, increased alanine aminotransferase, increased aspartate aminotransferase, hepatitis B and/or hepatitis C virus co-infection, death."
285,INVOKANA,all-concat,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Fatigue, Loss of strength or energy, Pancreatitis, Photosensitivity-related adverse reactions, Volume depletion-related adverse reactions, Falls, Significant renal function decline, Renal-related adverse reactions, Death."
286,JARDIANCE,all-concat,"Hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), death, hypovolemia, dehydration, blood pressure decreased, syncope, orthostatic hypotension, nocturia, polyuria, pollakiuria, increased creatinine, decreased eGFR, renal impairment, nausea, thirst, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, balanoposthitis, balanitis, genital infections fungal, genitourinary tract infection, balanitis candida, scrotal abscess, penile infection, phimosis."
287,JEVTANA,all-concat,"Neutropenia, anemia, leukopenia, thrombocytopenia, febrile neutropenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, gastritis, intestinal obstruction, death, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, renal failure, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis."
288,JUBLIA,all-concat,"Ingrown toenails, application site dermatitis, application site vesicles, application site pain, skin irritation, blisters"
289,KALBITOR,all-concat,"anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, hypersensitivity reactions, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension"
290,KALYDECO,all-concat,"Headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, rhinitis, arthralgia, bacteria in sputum, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, death, abnormal liver function tests, cataracts."
291,KYPROLIS,all-concat,"Anemia, fatigue, thrombocytopenia, nausea, pyrexia, decreased platelets, dyspnea, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, hypokalemia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal impairment, pulmonary embolism, pulmonary edema, deep vein thrombosis, hypotension, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, tumor lysis syndrome, decreased lymphocytes, decreased absolute neutrophil count, decreased phosphorus, decreased platelets, decreased total white blood cell count, decreased hemoglobin, decreased potassium, death."
292,LUMIZYME,all-concat,"Hypersensitivity reactions, including: Anaphylaxis, Rash, Pyrexia, Flushing/feeling hot, Urticaria, Headache, Hyperhidrosis, Nausea, Cough, Decreased oxygen saturation, Tachycardia, Tachypnea, Chest discomfort, Dizziness, Muscle twitching, Agitation, Cyanosis, Erythema, Hypertension/increased blood pressure, Pallor, Rigors, Tremor, Vomiting, Fatigue, Myalgia, Angioedema, Throat tightness, Chest pain/discomfort, Supraventricular tachycardia, Hyperhidrosis, Headache, Nausea, Urticaria, Dizziness, Chest discomfort, Muscle twitching, Myalgia, Flushing/feeling hot, Increased blood pressure, Vomiting, Peripheral edema, Pruritus, Rash papular, Throat tightness, Death (implied due to anaphylaxis)"
293,MULTAQ,all-concat,adverse reactions
294,NATAZIA,all-concat,"headache (including migraines), breast pain, discomfort or tenderness, menstrual disorders (metrorrhagia, menstruation irregular, menorrhagia, vaginal hemorrhage, dysfunctional uterine bleeding, genital hemorrhage, abnormal withdrawal bleeding, uterine hemorrhage), nausea or vomiting, acne, mood changes (depression, mood swings, depressed mood, mood altered, affect lability, dysthymic disorder, crying), increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, and chronic acalculous cholecystitis, venous and arterial thromboembolic events (including pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction and stroke), hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms (for example, abdominal pain), vulvovaginal candidiasis, death."
295,NESINA,all-concat,"Nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions (including anaphylaxis, angioedema, rash, urticaria, and severe cutaneous adverse reactions, such as Stevens-Johnson syndrome), hepatic failure, hypoglycemia, severe and disabling arthralgia, macrovascular outcomes, death."
296,NEURACEQ,all-concat,"injection site reaction (erythema, irritation, pain), image interpretation errors, false positives, cancer"
297,NORTHERA,all-concat,"Supine hypertension, hypertension, headache, dizziness, nausea, death, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions"
298,NULOJIX,all-concat,"Anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, post-transplant lymphoproliferative disorder (PTLD), CNS PTLD, non-CNS PTLD, malignancies excluding non-melanoma skin cancer, non-melanoma skin cancer, progressive multifocal leukoencephalopathy (PML), tuberculosis, herpes infections, fungal infections, BK virus-associated nephropathy, cryptococcal meningitis, drug hypersensitivity, infusion-related reactions, proteinuria, antibodies directed against the belatacept molecule, death (in case of PML)."
299,ONFI,all-concat,"Somnolence or Sedation, Potentiation of Sedation from Concomitant Use with Central Nervous System Depressants, Withdrawal Symptoms, Serious Dermatological Reactions (including Stevens-Johnson syndrome and toxic epidermal necrolysis), Physical and Psychological Dependence, Suicidal Behavior and Ideation, Anemia, eosinophilia, leukopenia, thrombocytopenia, Diplopia, vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, Urinary retention, respiratory depression, Rash, urticaria, angioedema, and facial and lip edema, Convulsions, psychosis, hallucinations, behavioral disorder, tremor, and anxiety."
300,OTEZLA,all-concat,"Diarrhea, nausea, headache, upper respiratory tract infection, tension headache, abdominal pain, vomiting, fatigue, dyspepsia, decreased appetite, insomnia, back pain, migraine, frequent bowel movements, depression, suicidal thoughts or behavior, weight decrease, severe worsening of psoriasis (rebound), death."
301,PICATO,all-concat,"Local skin reactions (including erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, and erosion/ulceration), application site pain, application site pruritus, application site infection, periorbital edema, headache, death, hypersensitivity reactions (including anaphylaxis and allergic contact dermatitis), herpes zoster, chemical conjunctivitis, corneal burn, eyelid edema, eye pain, conjunctivitis."
302,POTIGA,all-concat,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, death."
303,PRADAXA,all-concat,"Bleeding, intracranial hemorrhage, hemorrhagic stroke, other intracranial bleed, gastrointestinal bleeding, fatal bleeding, anaphylactic reaction, anaphylactic shock, angioedema, thrombocytopenia, esophageal ulcer, death."
304,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease and Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, LDL cholesterol increased, triglycerides increased, proteinuria, hypertension, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, tachycardia, death."
305,PROLIA,all-concat,"Hypocalcemia, serious infections, dermatologic reactions (such as dermatitis, eczema, and rashes), osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, death, drug-related hypersensitivity reactions (anaphylaxis, rash, urticaria, facial swelling, and erythema), musculoskeletal pain (including severe cases), and parathyroid hormone increased."
306,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, headache, hyperbilirubinemia, ALT increased, AST increased, fatigue, vitamin D deficiency, anemia, pyrexia, asthenia, insomnia, cough, pruritus, chills, myalgia, alopecia, peripheral edema, abdominal pain, toothache, diarrhea, Rash, vitamin D deficiency, anemia, pyrexia, fatigue, headache, nausea, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, myalgia, alopecia, peripheral edema, hyperbilirubinemia, total bilirubin greater than or equal to 1.5 x ULN, ALT or AST greater than or equal to 3 x ULN, nausea, fatigue, cough, diarrhea, headache, pain in extremity, dyspnea, pyrexia, dizziness, oropharyngeal pain, febrile neutropenia, abdominal pain, ecchymosis, death."
307,QUTENZA,all-concat,"application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, increase in blood pressure, death."
308,SAPHRIS,all-concat,"akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms other than akathisia, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, somnolence, oral hypoesthesia, dry mouth, dyspepsia, headache, arthralgia, pain in extremity, depression, insomnia, anxiety, dysgeusia, dyspnea, vomiting, hyperhidrosis, irritability, muscle rigidity, parkinsonism, gait disturbance, masked facies, tremor, hypertension, decreased appetite, abdominal pain, nausea, toothache, pain, agitation, akinesia, anxiety symptoms, confusion, hostility, hyperkinesia, lethargy, nervousness, paranoid reaction, psychotic depression, restlessness, sleep disorder, suicide ideation, syncope, tachycardia, vasodilatation, decreased blood pressure, hypertonia, hypotension, myalgia, neck pain, orthostatic hypotension, pain in jaw, photosensitivity reaction, short QT syndrome, substance withdrawal syndrome, vertigo, visual disturbance, diarrhea, dry mouth, dysmenorrhea, dyspepsia, eructation, fecaloma, flatulence, gastroesophageal reflux disease, gastrointestinal discomfort, gastrointestinal pain, hyperchlorhydria, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypoglycemia, hypokalemia, hyponatremia, increased alkaline phosphatase, increased amylase, increased bilirubin, increased creatine phosphokinase, increased eosinophils, increased gamma-glutamyltransferase, increased hematocrit, increased lactate dehydrogenase, increased neutrophils, increased non-protein nitrogen, increased prothrombin time, increased uric acid, leukocytosis, leukopenia, lymphocytosis, lymphopenia, monocytosis, proteinuria, thrombocythemia, thrombocytopenia, thrombocytosis, weight decreased, weight increased, anemia, neutropenia, pancytopenia, abnormal dreams, agitation, amnesia, anxiety, apathy, catatonia, cognitive disorder, confusional state, delirium, delusion, dementia, depression, dysarthria, emotional lability, excitation, hallucination, mania, neuroleptic malignant syndrome, obsessive-compulsive disorder, panic attack, phobic disorder, psychosis, sleep disorder, suicide attempt, thinking abnormal, amnesia, anxiety symptoms, confusion, delirium, depression, emotional lability, excitation, hallucination, hostility, insomnia, mania, neuroleptic malignant syndrome, obsessive-compulsive disorder, panic attack, phobic disorder, psychosis, sleep disorder, suicide attempt, thinking abnormal, abnormal electrocardiogram, abnormal hepatic function, abnormal liver function test, abnormal renal function, abnormal urine, alopecia, angioedema, anxiety, asthenia, back pain, bradycardia, chills, constipation, creatine phosphokinase increased, decreased appetite, decreased libido, diarrhea, diplopia, dizziness, dry mouth, dysarthria, dysgeusia, dysmenorrhea, dyspnea, ear pain, ecchymosis, emotional lability, eye pain, face edema, fall, feeling abnormal, flushing, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gastrointestinal pain, hyperacusis, hyperhidrosis, hyperkinesia, hyperlipidemia, hypertonia, hypersensitivity, hypesthesia, hypoglycemia, hypokalemia, hyponatremia, hypotension, hypoxia, infection, injection site reaction, insomnia, intestinal obstruction, leukocytosis, leukopenia, malaise, migraine, myalgia, neck pain, neuralgia, neutropenia, orthostatic hypotension, pain, pain in jaw, palpitations, paresthesia, pharyngitis, photosensitivity reaction, rash, respiratory disorder, restlessness, rhinitis, sinus headache, skin discoloration, speech disorder, stupor, sweating, syncope, tachycardia, thirst, tooth disorder, urinary retention, urticaria, vasodilatation, visual disturbance, weakness, xerostomia."
309,SIMPONI,all-concat,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, TB (pulmonary and extrapulmonary), ALT elevations, autoantibodies, autoimmune disorders, lupus-like syndrome, infusion reaction, leukopenia, immunogenicity, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, interstitial lung disease, skin exfoliation, bullous skin reactions, serious infections leading to hospitalization or death, tuberculosis (TB), bacterial sepsis, invasive fungal (such as histoplasmosis), other opportunistic infections, active tuberculosis, reactivation of latent tuberculosis, disseminated or extrapulmonary disease, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Legionella and Listeria, chronic or recurrent infection, lymphoma, other malignancies"
310,SIRTURO,all-concat,"Increased mortality, QT prolongation, death, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, Rash, blood amylase increased, hepatotoxicity, ventricular arrhythmia, QTcF interval >500 ms, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium, magnesium, or potassium levels below the lower limits of normal, clinically significant ventricular arrhythmia, aminotransferase elevations, total bilirubin elevation, hepatic function impairment, CYP3A4 inducers/inhibitors."
311,STENDRA,all-concat,"Headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, death."
312,STRIBILD,all-concat,"Lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, diarrhea, flatulence, nausea, vomiting, abdominal pain, dyspepsia, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, depression, suicidal ideation, suicide attempt, skin discoloration, abnormal dreams, fatigue, headache, dizziness, insomnia, jaundice, ocular icterus, somnolence, rash, eye disorders, gastrointestinal disorders, hepatobiliary disorders, nervous system disorders, psychiatric disorders, skin and subcutaneous tissue disorders, musculoskeletal and connective tissue disorders, renal and urinary disorders, general disorders and administration site conditions, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, proteinuria, polyuria, asthenia."
313,TAFINLAR,all-concat,"New primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, hypertension, pneumonitis or interstitial lung disease, death."
314,TANZEUM,all-concat,"Thyroid C-cell tumors, acute pancreatitis, hypoglycemia with concomitant use of insulin secretagogues or insulin, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, hypoglycemia, pneumonia, atrial fibrillation, atrial flutter, appendicitis, anti-albiglutide antibodies, anti-GLP-1 antibodies, anti-human albumin antibodies, liver enzyme abnormalities, death."
315,TECFIDERA,all-concat,"Anaphylaxis, angioedema, death, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, gastrointestinal events, increased hepatic transaminases, eosinophilia, serious infections."
316,TEFLARO,all-concat,"Diarrhea, nausea, rash, increased transaminases, hypokalemia, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, agranulocytosis, death."
317,TIVICAY,all-concat,"Insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, or completion, renal impairment, pruritus, elevated ALT, AST, hyperglycemia, elevated lipase, neutropenia, death."
318,TOVIAZ,all-concat,"Dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, peripheral edema, back pain, insomnia, increased alanine aminotransferase, increased gamma glutamyltransferase, rash, blurred vision, palpitations, hypersensitivity reactions including angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angioedema of the face, lips, tongue, and/or larynx, urinary retention, decreased gastrointestinal motility, narrow-angle glaucoma, anticholinergic central nervous system effects, hepatic impairment, severe renal impairment, concomitant administration with CYP3A4 inhibitors, myasthenia gravis, death."
319,TREANDA,all-concat,"Myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, hypersensitivity, hypertension, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, worsening hypertension, hypersensitivity, pyrexia, diarrhea, nasopharyngitis, infection, herpes simplex, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, nasopharyngitis, weight decreased, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, death."
320,TRULICITY,all-concat,"Thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, death."
321,TUDORZA,all-concat,"Paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions (anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching), death."
322,ULESFIA,all-concat,"Ocular irritation, application site irritation, application site anesthesia and hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, death (in the context of neonatal toxicity)"
323,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, Stevens Johnson Syndrome, hypersensitivity skin reactions, death."
324,VICTRELIS,all-concat,"Fatigue, anemia, nausea, headache, dysgeusia, neutropenia, diarrhea, vomiting, dry mouth, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, asthenia, exertional dyspnea, alopecia, dry skin, rash, death"
325,VIMIZIM,all-concat,"Anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, death."
326,VIZAMYL,all-concat,"Flushing, increased blood pressure, headache, nausea, dizziness, hypersensitivity reactions such as flushing and dyspnea, radiation risk"
327,VORAXAZE,all-concat,"Paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, death, anaphylactic reactions, serious allergic reactions."
328,XALKORI,all-concat,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, pneumonia, pulmonary embolism, ILD, sepsis, arrhythmia, dyspnea, fatigue, neuropathy, rash, renal cyst, syncope, pyrexia, weight decreased, muscle spasm, abdominal pain, dysphagia, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, diabetic ketoacidosis, septic shock, acute respiratory failure, death."
329,XEOMIN,all-concat,"Hypersensitivity, dysphagia, neck pain, muscle weakness, injection site pain, musculoskeletal pain, gastrointestinal disorders (dysphagia, dry mouth, diarrhea), visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, headache, eye disorders (eyelid ptosis, dry eye, visual impairment, eyelid edema, blepharospasm, eye disorder, eyelid ptosis), general disorders and administration site conditions (injection site hematoma, injection site pain, sensation of pressure), facial paresis (brow ptosis), muscle disorder (elevation of eyebrow), injection site swelling, allergic dermatitis, localized allergic reactions (swelling, edema, erythema, pruritus or rash), herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, hypersensitivity, death."
330,XIAFLEX,all-concat,"edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in extremity, tenderness, injection site swelling, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, blood blister, injection site hematoma, injection site swelling, ecchymosis, tendon rupture, death, penile hematoma, penile swelling, penile pain, penile ecchymoses, blood blister, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, corporal rupture, severe penile hematoma, death."
331,XTANDI,all-concat,"Asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, seizure, asthenic conditions, peripheral edema, musculoskeletal pain, arthralgia, muscular weakness, musculoskeletal stiffness, diarrhea, hot flush, hypertension, headache, dizziness, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, insomnia, anxiety, hematuria, restless legs syndrome, dyspnea, upper respiratory tract infection, lung infection, decreased appetite, weight decreased, gynecomastia, neutropenia, thrombocytopenia, ALT increased, bilirubin increased, infection, falls including fall-related injuries, death due to infections or sepsis, hypertension, seizure, death."
332,YERVOY,all-concat,"Immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, other immune-mediated adverse reactions including ocular manifestations, diarrhea, colitis, pruritus, rash, fatigue, skin and subcutaneous tissue disorders, gastrointestinal disorders, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, infusion reaction, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), enterocolitis, hepatitis, dermatitis (including toxic epidermal necrolysis), neuropathy, endocrinopathy, death."
333,ZERBAXA,all-concat,"Nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, increased alanine aminotransferase (ALT), increased aspartate aminotransferase (AST), anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, renal impairment, renal failure, venous thrombosis, death."
334,ZYDELIG,all-concat,"Hepatotoxicity, severe diarrhea or colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, death."
335,ZYKADIA,all-concat,"Diarrhea, nausea, vomiting, abdominal pain, abdominal discomfort, esophageal disorder, dyspepsia, gastroesophageal reflux disease, dysphagia, fatigue, asthenia, rash, maculopapular rash, acneiform dermatitis, gastrointestinal disorders, gastrointestinal toxicity, severe or persistent gastrointestinal toxicity, hepatotoxicity, interstitial lung disease/pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, decreased appetite, convulsion, pneumonia, respiratory failure, dehydration, hyperglycemia, cardiac tamponade, sepsis, diarrhea, nausea, vomiting, abdominal pain, constipation, esophageal disorder, fatigue, decreased appetite, rash, paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy, hemoglobin decreased, alanine transaminase (ALT) increased, aspartate transaminase (AST) increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin (total) increased, diarrhea, nausea, vomiting, abdominal pain, constipation, esophageal disorder, fatigue, decreased appetite, rash, paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy, diarrhea, severe or persistent gastrointestinal toxicity, hepatotoxicity, interstitial lung disease/pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, death."
336,ZYTIGA,all-concat,"fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, hypertension, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, hypokalemia, arrhythmia, chest pain or chest discomfort, cardiac failure, cardiac disorder, fractures, injury, poisoning and procedural complications, hypertriglyceridemia, high AST, hypokalemia, hypophosphatemia, high ALT, hypernatremia, hyperglycemia, lymphopenia, cardiovascular adverse reactions, non-infectious pneumonitis, myopathy, rhabdomyolysis, mineralocorticoid excess, death."
